ÄÌÌÇÖ±²¥

The Institutional Biosafety Committee (IBC) oversees all research involving biological materials including some molecules, bacteria, viruses, arthropods and recombinant DNA technology in accordance with guidance from the National Institutes of Health (NIH). In addition, if you are creating transgenic lines of organisms as research models, they could require approval from IBC.

Next IBC Meeting: November 4, 2024 - 10:00am

For location information, contact the IBC. 

To report compliance issues, call EthicsPoint Hotline toll free 1-955-236-1443.